ArticleFrontiers in pharmacology2023

Sodium-glucose co-transporter-2 inhibitor (SGLT2i) treatment and risk of osteomyelitis: A pharmacovigilance study of the FAERS database.

Hui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.